首页> 外文期刊>The Journal of Urology >Re: Long-Term Survival Following Partial vs Radical IMephreetomy Among Older Patients with Early-Stage Kidney Cancer
【24h】

Re: Long-Term Survival Following Partial vs Radical IMephreetomy Among Older Patients with Early-Stage Kidney Cancer

机译:回复:老年肾癌部分患者接受局部和根治性肾穿刺术后的长期生存

获取原文
获取原文并翻译 | 示例
       

摘要

Context: Although partial nephrectomy is the preferred treatment for many patients with early-stage kidney cancer, recent clinical trial data, which demonstrate better survival for patients treated with radical nephrectomy, have generated new uncertainty regarding the comparative effectiveness of these treatment options. Objective: To compare long-term survival after partial vs radical nephrectomy among a population-based patient cohort whose treatment reflects contemporary surgical practice. Design, Setting, and Patients: We performed a retrospective cohort study of Medicare beneficiaries with clinical stage Tla kidney cancer treated with partial or radical nephrectomy from 1992 through 2007. Using an instrumental variable approach to account for measured and unmeasured differences between treatment groups, we fit a 2-stage residual inclusion model to estimate the treatment effect of partial nephrectomy on long-term survival. Main Outcome Measures: Overall and kidney cancer-specific survival. Results: Among 7138 Medicare beneficiaries with early-stage kidney cancer, we identified 1925 patients (27.0%) treated with partial nephrectomy and 5213 patients (73.0%) treated with radical nephrectomy. During a median follow-up of 62 months, 487 (25.3%) and 2164 (41.5%) patients died following partial or radical nephrectomy, respectively. Kidney cancer was the cause of death for 37 patients (1.9%) treated with partial nephrectomy, and 222 patients (4.3%) treated with radical nephrectomy. Patients treated with partial nephrectomy had a significantly lower risk of death (hazard ratio [HR], 0.54; 95% CI, 0.34-0.85).
机译:背景:尽管部分肾切除术是许多早期肾癌患者的首选治疗方法,但最近的临床试验数据显示,这些治疗方案的相对有效性产生了新的不确定性,这些数据表明接受根治性肾切除术治疗的患者生存率更高。目的:比较部分人群和根治性肾切除术后人群的长期生存率,该人群基于治疗方法反映了当代手术实践。设计,背景和患者:我们对1992年至2007年间接受部分或根治性肾切除术治疗的Tla肾癌临床分期的Medicare受益人进行了一项回顾性队列研究。拟合2期残差纳入模型以评估部分肾切除术对长期生存的治疗效果。主要结果指标:总体生存期和特定于肾癌的生存期。结果:在7138名患有早期肾癌的Medicare受益人中,我们确定了1925例(27.0%)接受部分肾切除术的患者和5213例(73.0%)接受了根治性肾切除术的患者。在62个月的中位随访中,分别有487例(25.3%)和2164例(41.5%)的患者在部分或根治性肾切除术后死亡。肾癌是部分肾切除术治疗的37例患者(1.9%)和根治性肾切除术治疗的222例患者(4.3%)的死亡原因。经部分肾切除术治疗的患者死亡风险显着降低(危险比[HR]为0.54; 95%CI为0.34-0.85)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号